Clinical outcomes with paliperidone palmitate 3-monthly injection as monotherapy: observational 3-year follow-up of patients with schizophrenia

Abstract Background Paliperidone palmitate 3-monthly (PP3M) has been tested in 1-year controlled studies. The aim of this study was to examine the relapse outcomes with PP3M monotherapy at 3 years in patients with schizophrenia. Methods This was an observational, non-interventional study of pati...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Ivana Clark, Phoebe Wallman, Siobhan Gee, David Taylor
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Cambridge University Press 2024-01-01
Sarja:	European Psychiatry
Aiheet:	continuation long-acting paliperidone 3-month relapse schizophrenia
Linkit:	https://www.cambridge.org/core/product/identifier/S0924933824000130/type/journal_article
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!